Catalyst Wire Dossier Catalyst Wire Dossier

Duobrii

halobetasol propionate and tazarotene
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Duobrii, covering 2019-04-25 to 2025-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Duobrii Treatment of Acne Keloidalis Nuchae (AKN) [Phase 3]

See pricing